Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout

ClinicalTrials.gov ID: NCT06229145

Public ClinicalTrials.gov record NCT06229145. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 8:12 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 4, Randomized, Double-blind, Multicenter Non-inferiority Trial Evaluating the Efficacy and Safety of Intravenous KRYSTEXXA® (Pegloticase) Administered Every 4 Weeks Compared With KRYSTEXXA Administered Every 2 Weeks With Co-administration of Weekly Doses of Methotrexate, Followed by an Open-label Extension, in Participants With Uncontrolled Refractory Gout (FORWARD II)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study consists of 24-week double-blind trial to evaluate the non-inferiority of the efficacy and safety of pegloticase Q4W with MTX versus pegloticase Q2W with MTX, followed by a 24-week open-label extension of pegloticase Q4W with MTX, in participants with uncontrolled refractory gout. The main objective of the study is to evaluate the effect of pegloticase 16 mg administered Q4W with MTX versus pegloticase 8 mg administered Q2W with MTX, on the response rate during Month 6, as measured by the sustained normalization of sUA to \< 6 mg/dL for at least 80% of the time.

Study identification

NCT ID
NCT06229145
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Amgen
Industry
Enrollment
306 participants

Conditions and interventions

Conditions

Interventions

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 18, 2024 (Actual)
Primary completion
Jul 30, 2025 (Actual)
Completion
Mar 26, 2026 (Actual)
Last update posted
Sep 17, 2026

2024 – 2026

United States locations

U.S. sites
74
U.S. states
23
U.S. cities
66
Facility City State ZIP Site status
The University of Alabama at Birmingham (UAB) Birmingham Alabama 35233 —
Orthopedic Physicians Alaska - Rheumatology and Infusion Anchorage Alaska 99508-5234 —
Arizona Arthritis and Rheumatology Associates - Chandler Chandler Arizona 85225-2915 —
Arizona Arthritis and Rheumatology Rese Flagstaff Arizona 86001 —
Arizona Arthritis & Rheumatology Research, PLLC Gilbert Arizona 85297 —
Arizona Arthritis & Rheumatology Research, PLLC Mesa Arizona 85032 —
Arizona Arthritis and Rheumatology Research, PLLC Mesa Arizona 85210 —
Arizona Arthritis and Rheumatology Research, PLLC Phoenix Arizona 85037-4403 —
Arizona Arthritis and Rheumatology Research Phoenix Arizona 85037 —
Arizona Arthritis & Rheumatology Research, PLLC Sun City Arizona 85351 —
Arizona Arthritis and Rheumatology Tucson Arizona 85704 —
Covina Arthritis Clinic Covina California 91722 —
Medvin Clinical Research- Riverside Hemet California 92543 —
Velocity Clinical Research - Boise - ERN - PPDS North Hollywood California 83642 —
TriWest Research Associates San Diego California 92108 —
Precision Comprehensive Clinical Research Solutions San Leandro California 94578-2630 —
Saint John's Health Center - Providence St John's Health Ctr Santa Monica California 90404 —
C.V. Mehta MD Medical Corporation Temecula California 92592 —
Foothill Arthritis Tujunga California 91042 —
Medvin Clinical Research Whittier California 90602 —
University of Colorado Denver Aurora Colorado 80045 —
Lynn Institute of the Rockies Colorado Springs Colorado 80918 —
Denver Arthritis Clinic - Rheumatology Denver Colorado 80230 —
Arthritis & Rheumatic Disease Aventura Florida 33180-1204 —
Prohealth Research Center Doral Florida 33166 —
Life Clinical Trials Margate Florida 33063-5675 —
Homestead Associates in Research,Inc Miami Florida 33032-8225 —
D&H National Research Centers, Inc. Miami Florida 33155 —
Well Pharma Miami Florida 33173 —
Felicidad Medical Research, LLC. Miami Florida 33184 —
New Generation Of Medical Research Naples Florida 34104 —
IRIS Research & Development Plantation Florida 33324 —
D&H Pompano Research Center Pompano Beach Florida 33064 —
D&H Tamarac Research Center Tamarac Florida 33321 —
GCP Clinical Research Tampa Florida 33609 —
ClinPro Research Solutions, LLC Tampa Florida 33613 —
Arthritis Center of North Georgia Gainesville Georgia 30501 —
Vista Clinical Research, LLC Newnan Georgia 30265 —
Great Lakes Clin. Trials Chicago Illinois 60625 —
Conquest Research - Anesthesiology/Pain Medicine Chicago Illinois 60637 —
Great Lakes Clinical Trials - Gurnee Highland Park Illinois 60035 —
Crowley CORE - Illinois Bone and Joint Institute Hinsdale Illinois 60521 —
Lake Cumberland Rheumatology, PLLC New Albany Indiana 47150 —
L-MARC Research Center Louisville Kentucky 40213 —
Velocity CR - New Orleans Covington Louisiana 70433 —
Velocity CR - New Orleans New Orleans Louisiana 70121-2429 —
Michigan Medicine Ann Arbor Michigan 48109 —
June DO,PC Lansing Michigan 48911 —
Clinical Research Institute of Michigan, LLC Saint Clair Shores Michigan 48081 —
Inspire Santa Fe Medical Group Santa Fe New Mexico 87505 —
Velocity Clinical Research-Vestal Vestal New York 13850 —
OnSite Clinical Solutions, LLC Charlotte North Carolina 28226 —
Research Carolina Elite Denver North Carolina 28037 —
Triad Clinical Trials - Gastroenterology Greensboro North Carolina 27410 —
Accellacare of Hickory Hickory North Carolina 28602 —
Cape Fear Arthritis Care Leland North Carolina 28451-4168 —
Shelby Clinical Research - Family Medicine Shelby North Carolina 28152 —
Velocity Clinical Research- Cincinatti Cincinnati Ohio 45242 —
Velocity Clinical Research - Cleveland Cleveland Ohio 44122 —
Lynn Health Science Institute Oklahoma City Oklahoma 73111-3324 —
Altoona Center for Clinical Research Duncansville Pennsylvania 16635 —
Velocity Clinical Research, Spartanburg - Pulmonology Greenville South Carolina 29615 —
Premier Clinics Pa - Rock Hill, Sc Rock Hill South Carolina 29732 —
Low Country Rheumatology Summerville South Carolina 29486-7887 —
Amarillo Center for Clinical Research, Ltd. Amarillo Texas 79124 —
Clinical Trial Network Austin Texas 78750 —
Synergy Groups Medical LLC Houston Texas 77061 —
Pioneer Research Solutions, Inc. Houston Texas 77099 —
AIM Trials - Internal Medicine Plano Texas 75093 —
Clinical Trials of Texas, Inc. San Antonio Texas 78229 —
Texas Research Center Sugar Land Texas 77479 —
Velocity Clinical Research - Salt Lake City (West Jordan) West Jordan Utah 84088 —
Velocity Clinical Research-Portsmouth Portsmouth Virginia 23703-3200 —
Arthritis Northwest, PLLC - Research Spokane Washington 99204 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06229145, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 17, 2026 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06229145 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →